AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUL 61 min read$JOBY

Papadopoulos Didier sold $115K of JOBY

Papadopoulos Didier (President of Aircraft OEM) sold 12,939 shares of Joby Aviation, Inc. (JOBY) at $8.92 ($0.12M total) on 2026-07-02.

Original reporting
SEC EDGAR · Papadopoulos Didier
Published Jul 6, 2026, 10:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$JOBY
Neutral
high confidence
Mentioned
$JOBY
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JOBYNeutralLow
01

Why it matters

Because it is an insider sale without any company-specific news (no guidance, deal, or regulatory action), it is more relevant for sentiment/positioning than for fundamental repricing.

02

Market read

Traders may note the insider selling signal, but the filing alone does not provide a new catalyst for valuation.

03

What to watch

Insider sales often reflect scheduled liquidity needs; the filing does not state purpose, and the holdings after sale (160,620 shares) suggest continued ownership.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-06 after-hours; reflects sale executed 2026-07-02.

Background

The article is a primary-source SEC Form 4 insider transaction for Joby Aviation, reporting an open-market sale by an officer.

Company-level read

Ticker impact

$JOBYNeutralHigh confidence
Context

Joby Aviation officer Papadopoulos Didier sold 12,939 shares on 2026-07-02 at $8.9200/share, totaling $115,415.88, per Form 4.

Expected impact

Low near-term impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is an insider transaction (not a company disclosure), the size is modest, and there is no accompanying guidance, contract, or regulatory event in the text.

Market effects

Sector

Minimal—no sector-wide signal beyond a single insider sale in an aerospace/AV company.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The absence of a disclosed 10b5-1 plan could be interpreted as discretionary selling, but without context (taxes, diversification, personal liquidity) it’s not a reliable bearish signal.

Key entities

  • issuer
    Joby Aviation, Inc.

    Subject of the Form 4 insider transaction; officer sold shares on 2026-07-02.

  • insider
    Papadopoulos Didier

    President of Aircraft OEM; reported open-market sale of 12,939 shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

JOBY insider trading history →

Related articles

OCT 28
$JOBYMed

The Pentagon Is Now the eVTOL Industry's Biggest Customer. Here's How Much Revenue That's Actually Worth to Archer and Joby.

Joby Aviation (JOBY) and Archer Aviation (ACHR) face cash flow pressures and FAA certification delays. Both companies are pursuing defense contracts for early revenue. Joby has a $163M Air Force contract and acquired Resonant Sciences for $500M. Archer has a $142M Air Force contract and a deal with Anduril. Defense revenue is crucial for their financial stability.

finance.yahoo.com3 min
OCT 14
$JOBYMed

4 High-Risk Stocks Built for Big Returns

Joby Aviation aims to be a transportation-as-a-service company with its eVTOL aircraft, making progress with FAA-compliant and autonomous technology. Viking Therapeutics is developing obesity drug VK2735, showing promising weight loss data in trials. Both companies are high-risk, high-reward investments.

finance.yahoo.com3 min
OCT 14
$JOBYMed

Why Did ASTS, CIFR, JOBY Stocks Plunge To 52-Week Lows Today?

Joby Aviation (JOBY) reported a larger-than-expected Q2 loss of $0.25 per share, raising concerns about its financial resources. Barclays downgraded JOBY to 'Underweight', questioning its market potential and production capacity. ASTS, CIFR, and JOBY stocks have fallen 23-62% this year. Retail sentiment remains bullish despite the downturn.

finance.yahoo.com2 min
OCT 13
$JOBYMed

What Just Happened To Joby Stock?

Joby Aviation (JOBY) stock fell 68.4% in the year to October 12, 2026, despite the S&P 500 gaining 20.5%. Key events included a Goldman Sachs Sell rating, broader market adjustments, and a $116.9M damages ruling. Joby's Q2 2026 revenue was $39M, with a net loss of $245M. The company has $2.3B in cash and plans to spend $385M-$415M in the second half of 2026.

finance.yahoo.com2 min